A. Lescault

Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).

Robert M. Tanguay, J P Valet, A. Lescault et al. · PubMed · 1990 · 98 citations

Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions

Marie Arsenault, Claude Prévost, A. Lescault et al. · Neurology · 2006 · 86 citations

Rare Diseases, Mendelian Disorder, Ophthalmology +10

Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia

A Grenier, A. Lescault, Claude Laberge et al. · Clinica Chimica Acta · 1982 · 73 citations

Hereditary Tyrosinemia, Mass Screening, Medicine +5

Prenatal diagnosis of hereditary tyrosinaemia: Measurement of succinylacetone in amniotic fluid

R. Gagné, A. Lescault, A Grenier et al. · Prenatal Diagnosis · 1982 · 46 citations

Hereditary Tyrosinemias (Type I): A New Vista on Tyrosine Toxicity and Cancer

Claude Laberge, A. Lescault, Robert M. Tanguay · 1986 · 25 citations

New Vista, Hereditary Tyrosinemias, Tyrosine Toxicity +4